During the past decade, Atlanta Center for Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta Center for Clinical Research" #1 sponsor was "Pfizer" with 3 trials, followed by "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored, "Mannkind Corporation" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Phathom Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta Center for Clinical Research" #1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta Center for Clinical Research" are "Cardiovascular Disease" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Diabetes Type 2" (1 trials), "Gastroesophageal Reflux Disease (GERD)" (1 trials) and "Heartburn" (1 trials). Many other conditions were trialed in "Atlanta Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Atlanta Center for Clinical Research" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "IW-3718" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Center for Clinical Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Atlanta Center for Clinical Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Atlanta Center for Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Center for Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".